BRAFTOVI Patient Financial Assistance

This program, BRAFTOVI Patient Financial Assistance, provides financial support primarily for the cost of BRAFTOVI and MEKTOVI medications. It offers co-pay assistance for commercially insured patients and helps Medicare/government insured and uninsured patients find resources like the Pfizer Patient Assistance Program, Extra Help, or Medicaid to obtain free or reduced-cost medication. The page does not mention any assistance for travel expenses.

Eligibility

Assistance is available to U.S. residents with BRAF+ metastatic melanoma, colorectal cancer, or non-small cell lung cancer. Commercially insured patients may receive co-pay support, while uninsured or government-insured patients may qualify for free medication based on financial need.